Atlas Trials

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer

Clinical trial NCT00021060 · COMPLETED

Trial details

NCT number
NCT00021060
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Adenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Start date
2002-08-01
Primary completion
2006-09-01
Enrollment
842

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.